Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid

Journal of Cellular Biochemistry

Volumn 100, Issue 1, 2007, Pages 184-190

  Johnson, David R ^a   Stebulis, Judith A ^a   Rossetti, Ronald G ^a   Burstein, Sumner H ^a   Zurier, Robert B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cannabinoids; Inflammation; Metalloproteinases

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; AJULEMIC ACID; CANNABINOID; GELATINASE B; INTERLEUKIN 1ALPHA; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; STROMELYSIN; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTHROPATHY; ARTICLE; BONE EROSION; CARTILAGE DEGENERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME REPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; CARTILAGE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMBRYO; FIBROBLASTS; HUMANS; INTERLEUKIN-1ALPHA; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; PPAR GAMMA; RATS; SYNOVIAL FLUID; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR-ALPHA;

DIOSCOREA TRIFIDA;

EID: 33845632330     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21046     Document Type: Article

References (26)

1. Abel EL. 1980. Marjuana: The first twelve thousand years. NY: Plenum.
2. Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, Firestein G. 1998. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 152:1091-1098.
3. Bidinger B, Torres R, Rossetti RG, Brown L, Beltre R, Burstein S, Lian JB, Stein GS, Zurier RB. 2003. Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes. Clin Immunol 108:95-102.
4. Brinckerhoff CE, Matrisian LM. 2002. Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol 3:207-214.
5. Burstein SH. 1999. The cannabinoid acids: Nonpsychoactive derivatives with therapeutic potential. Pharmacol Therap 82:87-96.
6. Burstein SH, Audette CA, Breuer A, Devane WA, Colodner S, Doyle SA, Mechoulam R. 1992. Synthetic nonpsychotropic cannabinoids with potent anti-inflammatory, analgesic, and leukocyte anti-adhesion activities. J Med Chem 35:3135-3141.
7. Cunnane G, Fitzgerald O, Hummel KM, Gay RE, Gay S, Bresnihan B. 1999. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology 38:34-42.
8. Dajani EZ, Larsen KR, Taylor J, Dajani NE, Shawan TG, Neelema SD, Taylor MS, Dayton MT, Mir GN. 1999. 1′1′ dimethylheptyl-A8- tetrahydrocannabinol-11-oic acid: A novel, orally effective cannabinoid with analgesic and antiinflammatory properties. J Pharmacol Exp Ther 291:31-38.
9. Fahmi H, Pelletier JP, DiBattista JA, Cheung HS, Fernandes JC, Martel-Pelletier J. 2002a. Peroxisome proliferator receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of activator-protein 1. Osteoarthritis Cartilage 10:100-108.
10. Fahmi H, Pelletier JP, Martel-Pelletier J. 2002b. PPAR gamma ligand as modulators of inflammatory and catabolic responses in arthritis. An overview. J Rheumatol 29:3-14.
11. Ferroni P, Basili S, Martini F, Cardarello CM, Ceci F, DiFranco M, Bertazzoni G, Gazzaniga PP, Alessandri C. 2003. Serum metalloproteinase 9 levels in patients with coronary artery disease: A novel marker of inflammation. J Investig Med 51(5):295-300.
12. Jiang C, Ting AT, Seed B. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
13. Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. 2003. Analgesic effect of the synthetic cannabinoid CT3 on chronic neuropathic pain. JAMA 290:1757-1762.
14. Lehmann JM, Lenhand JM, Oliver BB, Ringold GM, Kliewer SA. 1997. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272:3406-3410.
15. Liu J, Li H, Burstein SH, Zurier RB, Chen JD. 2003. Activation and binding of peroxisome proliferator-activated receptor gamma by a synthetic cannabinoid, ajulemic acid. Mol Pharmacol 65:983-992.
16. Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FM, Hutchinson NI, Stetler-Stevenson WG, Goldberg GI. 1993. Expression of 92-kD type IV collagenase/gelatinase in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest 92:179-185.
17. Muller-Ladner U, Kriegsmann J, Gay RE, Koopman WJ, Gay S, Chatman WW. 1995. Progressive joint destruction in a human immunodeficiency virus-infected patient with rheumatoid arthritis. Arthritis Rheum 38:1328-1332.
18. Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I. 2002. Matrix metalloproteinases in arthritic disease. Arthritis Res Therap 4(suppl 3):839-849.
19. Nagase H, Woessner JF Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
20. Pap T, Pap G, Hummel KM, Franz JK, Jeisy E, Sainsbury I, Gay RE, Billingham M, Neumann W, Gay S. 1999. Membrane-type-1 matrix metalloproteinase is abundantly expressed in fibroblasts and osteoclasts at the bone - Implant interface of aseptically loosened joint arthroplasties in situ. J Rheumatol 26:166-169.
21. Scher JU, Pillinger MH. 2005. 15d-PGJ2: The anti-inflammatory prostaglandin? Clin Immunol 115:118-128.
22. Stebulis JA, Rossetti RG, Atez FJ, Zurier RB. 2005. Fibroblast-like synovial cells derived from synovial fluid. J Rheumatol 32:301-306.
23. Yamanishi Y, Firestein GS. 2001. Pathogenesis of rheumatoid arthritis: The role of synoviocytes. Rheum Dis Clin N Am 27:355-371.
24. Zingarelli B, Cook JA. 2005. Peroxisome proliferator-activiated receptor-gamma is a new therapeutic target in sepsis and inflammation. Shock 23:393-399.
25. Zurier RB, Rossetti RG, Lane JH, Goldberg JM, Hunter SH, Burstein SH. 1998. Dimethylheptyl-THC-11 oic acid. A nonpsychoactive antinflammatory agent with a cannabinoid template structure. Arthritis Rheum 41:163-170.
26. Zurier RB, Rossetti RG, Burstein SH, Bidinger B. 2003. Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid. Biochem Pharmacol 65:649-655.